Timothy M. Carlton

Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology—Children and Adolescents (SONG-KIDS) consensus workshops

Camilla S. Hanson, Jonathan C. Craig, Charlotte Logeman et al. · Kidney International · 2020 · 94 citations · Full text

Medicine, Nephrology, Pediatrics +14

Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease

Jenny Crowe, Kevin J. Roberts, Timothy M. Carlton et al. · Scientific Reports · 2018 · 58 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeys

Jenny Crowe, Kevin J. Roberts, Timothy M. Carlton et al. · Drug Development and Industrial Pharmacy · 2018 · 41 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients

Suhail Nurbhai, Kevin J. Roberts, Timothy M. Carlton et al. · Scientific Reports · 2019 · 38 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease

Kevin J. Roberts, Marion F. Cubitt, Timothy M. Carlton et al. · Scientific Reports · 2021 · 32 citations · Full text

Pharmacy, Immunology, Pathology +17